Director/PDMR Shareholding - Replacement

Source: RNS
RNS Number : 1186W
Rentokil Initial PLC
12 April 2019
 

 

Rentokil Initial plc (the Company)

 

The following amendment has been made to the Director/PDMR Shareholding announcement released on 11 April 2019 at 16:37 under RNS No 9600V.

 

The correct share price achieved on the transaction was £3.6393314 not £3.638606 as previously announced.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

Rentokil Initial plc (the Company)

The Company hereby announces that the awards granted under the Rentokil Initial plc Performance Share Plan (PSP) in March 2015 and March 2016 to Jürgen Höfling (a person discharging managerial responsibility) have been exercised with 150,510 shares subsequently being sold at a share price of 363.93314p to cover his tax liability.

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Jürgen Höfling

 

2

 

Reason for the notification

 

a)

 

Position/status

 

Managing Director, Europe 

 

 

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Rentokil Initial plc

b)

 

LEI

 

 

549300VN4WV7Z6T14K68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 1p each

 

 

ISIN: GB00B082RF11

 

b)

 

Nature of the transaction

 

 

Exercise of awards made under the Company's Performance Share Plan (PSP).

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

Nil consideration

 

300,086

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

300,086 shares

 

 

-

 

e)

 

Date of the transaction

 

 

11 April 2019

f)

 

Place of the transaction

 

 

Outside a trading venue

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Jürgen Höfling

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Managing Director, Europe

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Rentokil Initial plc

b)

 

LEI

 

 

549300VN4WV7Z6T14K68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 1p each

 

 

ISIN: GB00B082RF11

 

 

 

b)

 

Nature of the transaction

 

 

Sale of shares to cover the tax liability arising following the exercise of awards made under the Company's Performance Share Plan (PSP).

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

£3.6393314

 

150,510

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

150,510 shares

 

 

£547,755.769

 

e)

 

Date of the transaction

 

 

11 April 2019

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

 

Enquiries:

 

Catherine Stead, Assistant Company Secretary     Rentokil Initial plc              01276 607444

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHITMRTMBMBBLL